4//SEC Filing
Stephens Kristin 4
Accession 0000950170-24-129384
CIK 0001556263other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:00 PM ET
Size
4.5 KB
Accession
0000950170-24-129384
Insider Transaction Report
Form 4
Stephens Kristin
Chief Development Officer
Transactions
- Sale
Common Stock
2024-11-18$0.22/sh−36,133$7,949→ 0 total
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001865490
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:00 PM ET
- Size
- 4.5 KB